Several halogenated alkenes are nephrotoxic; some others induce renal tubular adenocarcinomas in rodents after lifelong administration. A bioactivation mechanism accounting for the organ-selective tumor induction has been elucidated: conjugation of the parent compounds with glutathione (GSH), catalyzed by hepatic GSH S-transferases, results in the formation of haloalkyl and halovinyl glutathione S-conjugates. Formation of S-conjugates (identified by NMR and mass spectrometry) could be demonstrated with trichloroethene, tetrachloroethene, hexachlorobutadiene, perfluoropropene, trichlorotrifluoropropene, and dichloroacetylene in incubations with rat liver microsomes and in the isolated perfused rat liver. The GSH conjugates formed are eliminated from the rat liver with the bile and may be translocated to the kidney, intact or after metabolism to the corresponding cysteine S-conjugates that are metabolized in the kidney by renal tubular cysteine conjugate 3-lyase (P-lyase) to reactive intermediates, most likely thioacylchlorides and thioketenes. Interaction of these potent electrophiles with DNA [demonstrated for intermediates formed from S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine] causes mutagenicity in bacteria, genotoxicity in cultured renal cells, and cytotoxicity in kidney cells. As an alternative to 3-lyase-catalyzed cleavage, the cysteine S-conjugates may be acetylated to the corresponding mercapturic acids, which have been identified in urine. The ability of the kidney to concentrate GSH and cysteine S-conjugates and the intensive metabolism of GSH S-conjugates to cysteine S-conjugates in this organ are evidently responsible for the organotropic carcinogenicity.
Introduction
Several halogenated alkenes, e.g., hexachlorobutadiene (HCBD), perfluoropropene (PFP), trichlorotrifluoropropene (TCTFP), and the alkyne dichloroacetylene (DCA), are selectively nephrotoxic in rats and induce proximal tubular damage (1) . Moreover, the widely used solvents trichloroethene and tetrachloroethene, DCA, and HCBD induce carcinoma of the proximal tubules in rats. Recent studies that have sought an explanation for the selective nephrotoxicity and carcinogenicity of these compounds have elucidated a bioactivation mechanism that involves glutathione (GSH) S-conjugate formation, translocation to the kidney before or after metabolism to the corresponding cysteine S-conjugates, and, finally, metabolism by renal cysteine conjugate 3-lyase to yield pyruvate, ammonia, and reactive electrophiles presumably responsible for the nephrotoxicity of the parent compounds and the cytotoxicity of the derived amino acid S-conjugates (2). With all halogenated hydrocarbon substrates studied, the extent of GSH S-conjugate formation is much higher with liver microsomes than with liver cytosol (2), a reversal of the situation observed with most other substrates for GSH S-transferases. This effect may be due to a preferential distribution of the highly lipophilic haloalkenes into lipid membranes, thus generating high substrate concentrations for the membrane-bound enzymes.
In rats, metabolites indicative of GSH S-conjugate formation have also been identified. In the bile of rats exposed to trichloroethene, tetrachloroethene, HCBD, TCTFP, or PFP, GSH S-conjugates identical to those formed in liver microsomes were present; in urine of exposed animals, halovinylmercapturic acids were definitively identified, demonstrating that GSH S-conjugate formation occurs in vivo (2) .
Genotoxicity of S-Conjugates in Bacteria
Chlorovinyl-substituted cysteine S-conjugates are mutagenic in the Ames preincubation test in the absence of activating enzymes (3) . These cysteine S-conjugates are converted to reactive intermediates and pyruvate by P-lyase present in the Salmonella typhimurium strain used. GSH S-conjugates derived from chlorinated alkenes require processing by y-glutamyl transpeptidase (GGT) and dipeptidases to yield cysteine S-conjugates as penultimate toxic intermediates. Accordingly, the GSH S-conjugates derived from HCBD, trichloroethene, tetrachloroethene, TCTFP, and DCA were definite mutagens in the Ames test in the presence of rat kidney particulate fractions containing high GGT and dipeptidase activities.
To evaluate the genotoxicity of GSH S-conjugates and cysteine S-conjugates in mammalian cells, the bioactivation and detoxication mechanisms, transport properties, and DNA repair capabilities in renal proximal tubular cells were studied by using an essay to determine unscheduled DNA-synthesis (UDS) in a porcine kidney cell line (LLC PK1) (4, 5) . All halovinyl GSH and cysteine S-conjugate tested induce GGT Fig. 1) : Reactive intermediates were generated from S-conjugates by 3-elimination and transformed to stable, characterizable products (6, 7) ; and chlorinated enethiols, the initial metabolites formed from S-conjugates, were generated nonenzymatically in an inert solvent, and reactive intermediates were trapped and characterized.
Metabolism of halovinyl S-conjugates by bacterial ,3-lyase and by an N-dodecyl-pyridoxal bromide-based model system yielded halogenated acids. Reactions in the presence of diethylamine to transform intermediate acylating agents to stable products yielded the corresponding thioamides.
Cleavage of the sulfur-sulfur bond in chlorovinyl-2-nitrophenyl disulfides yields a-chlorinated enethiols (Fig. 1) , as does metabolism of cysteine S-conjugates by P-lyase (2 to undergo Diels-Alder reactions with cyclopentadiene was used. When pentachlorobutadienyl 2-nitrophenyl disulfide was reduced in the presence of cyclopentadiene, a cyclopentadiene adduct indicative of a thioketene intermediate was identified (Fig. 1) . In summary, these results suggest that thioketenes are the ultimate reactive intermediates formed by 3-lyase-dependent metabolism of cysteine S-conjugates and that their interaction with macromolecules is responsible for S-conjugate induced cytotoxicity and DNA-damage. The reactive intermediates formed from cysteine Sconjugates also modify DNA both in vitro and in vivo. DNA isolated from rat kidney cells and bacteria treated with 35S- (1,2,3,4,4-pentachlorobutadienyl (10); b) the distribution of GSH S-conjugate processing enzymes. GSH S-conjugates require processing by GGT and dipeptidases prior to ,B-lyase-dependent bioactivation (1) . GGT in mammals is mainly concentrated in the brush-border membrane of the proximal tubular cells. This enzyme distribution may also contribute to an increase in the concentration of cysteine S-conjugates in the target cells.
The importance of GSH-dependent metabolism of trichloroethene and tetrachloroethene for the nephrocarcinogenicity of the parent compounds cannot be precisely defined at present. The amounts of S-conjugates formed and bioactivated by ,B-lyase seem small and relatively insignificant (11, 12) . However, as described previously for the potent nephrotoxin HCBD, where only a small fraction of the HCBD given is bioactivated in the kidney (13) , the contribution of the GSH S-conjugate/,3-lyase pathway may result in nephrocarcinogenicity for trichloroethene and tetrachloroethene too, especially under the conditions of long-term bioassays with high doses. Moreover, trichloroethene inhibits its oxidative metabolism by suicidal inactivation of cytochrome P-450 (14) ; GSH conjugation reactions may, therefore, play a more important role in trichloroethene and, perhaps, also tetrachloroethene metabolism during long-term application of high doses than it does in the single dose metabolism studies carried out to date.
Trichloroethene, tetrachloroethene, and HCBD increase the incidence of renal neoplasms in rats, but only at doses that also induce severe nephrotoxicity. Tumor induction was not observed after nontoxic doses. In addition, trichloroethene and tetrachloroethene induce a low rate of renal tumors exclusively in male rats.
The formation of S-conjugates and their renal activation by 13-lyase may be involved in this organ-specific ,B-lyase-dependent mutagens in bacteria, and they induce DNA damage in mammalian cells. They are, however, also highly cytotoxic in renal proximal tubular cells. These in vitro results, the very low level of genotoxicity of HCBD in the kidney in vivo (15) , and the severe chronic nephrotoxicity observed in long-term tumorigenicity studies indicate that both genotoxic and nongenotoxic mechanisms might contribute to haloalkene nephrocarcinogenicity. The DNA damage induced by cysteine S-conjugates of haloalkenes and the observed binding of HCBD-metabolites to renal DNA, however, suggests that genotoxic mechanisms are operative in the carcinogenicity of these haloalkenes.
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